A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma
Clinical trial NCT04568304 · WITHDRAWN
Trial details
- NCT number
- NCT04568304
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-06
- Primary completion
- 2022-09-06
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.